Subscribe To
FRX / Buying Fennec Pharma Ahead Of September PDUFA For Pedmark
PDUFA for Pedmark (sodium thiosulfate) in treating platinum chemotherapy-induced cytotoxicity (ear toxicity) in children is scheduled on September 23. The company resolved the issues raised in the second CRL within 3 months and announced the NDA acceptance in April this year.
Read More
Posted: Aug 22 2022, 23:37
Author Name: Seeking Alpha
Views: 112536
FRX News
By Seeking Alpha
August 22, 2022
Buying Fennec Pharma Ahead Of September PDUFA For Pedmark
PDUFA for Pedmark (sodium thiosulfate) in treating platinum chemotherapy-induced cytotoxicity (ear toxicity) in children is scheduled on September 23. more_horizontal